We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4042:TSETosoh Corporation Analysis

Data as of 2026-03-14 - not real-time

¥2,409.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Price action shows the stock trading above its short‑term moving average while still lagging the long‑term trend, indicating a mixed technical picture. Momentum indicators point to oversold conditions with a low RSI and a bearish MACD histogram, yet the overall trend flag is bullish and volume is on the rise, suggesting potential short‑term upside.
Fundamentally, the market price sits well above the discounted cash‑flow derived fair value, implying an overvaluation bias, but the company delivers a high dividend yield supported by strong operating cash flow and a generous payout ratio. Revenue growth is negative, and the debt‑to‑equity ratio is elevated, which tempers the attractiveness despite the solid dividend profile. The stock’s low beta reduces market‑wide exposure, while elevated 30‑day volatility and sector‑specific regulatory considerations introduce moderate risk. Investors should weigh the dividend income against the valuation premium and earnings slowdown when deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram despite bullish trend flag
  • Low RSI indicating oversold momentum
  • Increasing trading volume supporting potential bounce

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Market price above DCF fair value creating valuation pressure
  • Negative revenue growth and high debt‑to‑equity ratio
  • Attractive dividend yield backed by solid cash flow

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustainable dividend income with high payout ratio
  • Low beta offering defensive characteristics
  • Sector exposure to basic materials with moderate regulatory headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth-4.20%
P/E Ratio19.0
Debt/Equity23.58
P/B Ratio0.9
Op. Cash Flow¥132.0B
Free Cash Flow¥44.9B

Technical Analysis

TrendBullish
RSI39.3
Support¥2,360.50
Resistance¥2,729.50
MA 20¥2,576.13
MA 50¥2,539.59
MA 200¥2,314.65
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value¥1,736.30
Target Price¥2,508.75
Upside/Downside4.12%
GradeOvervalued
TypeValue
Dividend Yield4.15%

Risk Assessment

Beta0.48
Volatility43.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.